Table 1.
# of gaps and breaks/cells scored (%) | ||
---|---|---|
Cells | FRA3B (FHIT) | FRA3O (NLGN1) |
WT GM11713 + APH | 16/50 (32%) | 8/50 (16%) |
KO Clone 1 + APH | 1/50 (2%) ** | 13/50 (26%) |
KO Clone 2 + APH | 0/50 (0%) ** | 10/38 (26%) |
WT GM11713 and its promoterless derivatives were subjected to FISH-based CFS analysis at FRA3B and FRA3O. Statistical analysis was by Fisher’s exact test, comparing each clone to WT; **, P < 0.0001. Fifty cells from each cell type without APH treatment were also scored and none showed gaps or breaks at these loci.